Evidence map›Paper›PMID 30249311›Full record

ArticleEpidemiology and infection2018

Tularemia transmission to humans: a multifaceted surveillance approach.

N Akhvlediani, I Burjanadze, D Baliashvili, T Tushishvili, M Broladze, A Navdarashvili, S Dolbadze, N Chitadze, M Topuridze, P Imnadze and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Microorganisms · 2021
    Review
  4. Seroepidemiology, Spatial Distribution, and Risk Factors ofThe American journal of tropical medicine and hygiene · 2020
    Article
  5. Frontiers in cellular and infection microbiology · 2020
    Review
  6. Vaccines for emerging pathogens: prospects for licensure.Clinical and experimental immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

N AkhvledianiDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
I BurjanadzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
D BaliashviliDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
T TushishviliDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
M BroladzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
A NavdarashviliDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
S DolbadzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
N ChitadzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
M TopuridzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
P ImnadzeDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
N KazakhashviliDepartment of Epidemiology,Ivane Javakhishvili Tbilisi State University,Tbilisi,Georgia.
T TsertsvadzeInfectious Diseases, AIDS and Clinical Immunology Research Centre,Tbilisi,Georgia.
T KuchuloriaDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
T AkhvledianiDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.
L-A McNuttInstitute for Health and the Environment, University at Albany, State University of New York,NY,USA.ORCID 0000-0003-3960-7494
G ChanturiaDepartment of Molecular Epidemiology,National Centre for Disease Control and Public Health,Tbilisi,Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tularemia has sustained seroprevalence in Eurasia, with estimates as high as 15% in endemic regions. The purpose of this report is to characterise the current epidemiology of Francisella tularensis subspecies holarctica in Georgia. Three surveillance activities are summarised: (1) acute infections captured in Georgia's notifiable disease surveillance system, (2) infectious disease seroprevalence study of military volunteers, and (3) a study of seroprevalence and risk factors in endemic regions. Descriptive analyses of demographic, exposure and clinical factors were conducted for the surveillance studies; bivariate analyses were computed to identify risk factors of seropositivity using likelihood ratio χ2 tests or Fisher's exact tests. Of the 19 incident cases reported between 2014 and August 2017, 10 were confirmed and nine met the presumptive definition; the estimated annual incidence was 0.12/100 000. The first cases of tularemia in Western Georgia were reported. Seroprevalences of antibodies for F. tularensis were 2.0% for military volunteers and 5.0% for residents in endemic regions. Exposures correlated with seropositivity included work with hay and contact with multiple types of animals. Seroprevalence studies conducted periodically may enhance our understanding of tularemia in countries with dramatically underestimated incidence rates.

Indexed as

Disease Transmission, InfectiousEpidemiological MonitoringAdolescentAdultAgedAnimalsAntibodies, BacterialEnvironmental ExposureFemaleFrancisella tularensisGeorgia (Republic)HumansIncidenceMaleMiddle AgedRisk FactorsAntibodies, BacterialEpidemiologyGeorgiasurveillancetularemia

Identifiers

PMID30249311
PMCPMC6453017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.